chlortetracycline

chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with chlortetracycline?

chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with chlortetracycline

MeSH term MeSH ID Detail
Lymphadenitis D008199 8 associated lipids
Pasteurella Infections D010326 8 associated lipids
Cross Infection D003428 9 associated lipids
Urethritis D014526 9 associated lipids
Tooth, Impacted D014095 9 associated lipids
Pneumonia D011014 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Otitis Media D010033 12 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Per page 10 20 50 | Total 49

PubChem Associated disorders and diseases

What pathways are associated with chlortetracycline

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with chlortetracycline?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with chlortetracycline?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with chlortetracycline?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with chlortetracycline?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with chlortetracycline?

Mouse Model

Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with chlortetracycline

Download all related citations
Per page 10 20 50 100 | Total 4669
Authors Title Published Journal PubMed Link
GOGOLAK FM and WEISS E The effect of antibiotics on agents of the psittacosis-lymphogranuloma group. 1950 Nov-Dec J. Infect. Dis. pmid:14794967
HYMAN C Kaposi's varicelliform eruption treated with aureomycin. 1950 Nov-Dec Ann Allergy pmid:14800180
FU CK Aureomycin in typhus fever. 1950 Nov-Dec Chin Med J pmid:14801828
GARNIER G [Tentative evaluation of aureomycin in dermatology]. 1950 Nov-Dec Bull Soc Fr Dermatol Syphiligr pmid:14821742
POLI M [Increase of cholesterinemic rate during penicillin and aureomycin therapy]. 1950 Nov-Dec Boll. Soc. Ital. Biol. Sper. pmid:14839076
JANBON M and BERTRAND L [First experience with treatment of brucellosis from Br. melitensis by aureomycin; results in 50 cases, 32 with minimum follow-up of 6 months]. 1950 Oct 13-20 Bull Mem Soc Med Hop Paris pmid:14792284
SIGUIER F et al. [Aureomycin in the treatment of acute evolutive intestinal amebiasis]. 1950 Oct 13-20 Bull Mem Soc Med Hop Paris pmid:14792286
KHOURY MB [Aureomycin in the treatment of brucellosis]. 1950 Oct-Dec Rev Med Moyen Orient pmid:14816874
DE BERARDINIS E and BONAVOLONTA A [Aureomycin in opthalmology]. 1950 Oct-Dec Riv Ist Sieroter Ital pmid:14817032
IZAR G [Treatment of amebiasis and the importance of rhythmic therapy]. 1950 Sep 15-30 Rass Int Clin Ter pmid:14786470
PELNER LL and WALDMAN S Some newer aspects of the biology of infectious mononucleosis. 1950 Sep-Oct Ann Allergy pmid:14800147
BROWN EB and GOODGOLD M Allergic reaction to aureomycin with demonstration of a positive skin test to serum containing aureomycin. 1951 J Allergy pmid:14841015
COUNCIL announces classification of additional products. 1951 J Am Dent Assoc pmid:14784413
BALDRIDGE GD and KLIGMAN AM Preliminary and short reports; effect of aureomycin and terramycin on the vaccinia virus in the chick embryo. 1951 J. Invest. Dermatol. pmid:14803817
SBOROV VM et al. The effect of aureomycin on urobilinogen formation and the fecal flora. 1951 J. Lab. Clin. Med. pmid:14803848
LEVINSON DC et al. Antibiotics in management of staphylococcal endocarditis; with special reference to increasing bacterial resistance. 1951 Calif Med pmid:14812349
SPINELLI NP et al. Aureomycin in the treatment of mumps orchitis and encephalitis. 1951 Conn State Med J pmid:14812826
MORTON JH et al. The use of aureomycin in experimental intestinal obstruction. 1951 Ann. Surg. pmid:14895127
FLIPPIN HF et al. Aureomycin, chloramphenicol, and penicillin in treatment of bacterial pneumonia. 1951 J Am Med Assoc pmid:14873593
STAGG JF and LEIBOVITZ A Aureomycin and penicillin therapy in canicola fever; report of a case. 1951 J Am Med Assoc pmid:14873620
GITTELL G Unusual reaction to aureomycin. 1951 J Am Med Assoc pmid:14873646
VIGLIOGLIA PA [Aureomycin in dermatology]. 1951 Dia Med pmid:14896800
SHAH MA Aureomycin in trachoma. 1951 Br J Ophthalmol pmid:14821279
PATTON J [Aureomycin therapy]. 1951 Clin Lab (Zaragoza) pmid:14887086
DEGLI ESPOSTI A [Effect of aureomycin on vaccination]. 1951 Clin Pediatr (Bologna) pmid:14887087
LANDUCCI L [Aureomycin therapy of a case of Kaposi's varicelliform eruption]. 1951 Clin Pediatr (Bologna) pmid:14887088
ROTH LH A summary of the forms of aureomycin used in dentistry. 1951 N Y State Dent J pmid:14882523
GOLDNER JL and GAILEY HA Aureomycin and its use in the treatment of chronic osteomyelitis. 1951 N C Med J pmid:14882635
ZINK A et al. Listeriosis; field and laboratory studies, and aureomycin activity. 1951 Am. J. Vet. Res. pmid:14847112
EL-DIN GN Aureomycin in the treatment of malaria. 1951 J Egypt Med Assoc pmid:14909133
VARKONYI G [Aureomycin therapy]. 1951 Orv Hetil pmid:13046844
CUNINGHAM JA Aureomycin in brucellosis. 1951 N. Z. Med. J. pmid:14853155
FOOTE LE et al. The use of aureomycin in anaplasmosis. 1951 North Am Vet pmid:14853268
STOWENS D Aureomycin in the treatment of fibrocystic disease of the pancreas; clinical and metabolic studies. 1951 Pediatrics pmid:14853618
EKHOLM A [Local administration of aureomycin in cases of osteomyelitis of the jaw]. 1951 Odontol Tidskr pmid:14929500
IRGANG S and ALEXANDER ER Treatment of early syphilis with aureomycin; report based on a study of sixty-eight cases. 1951 Harlem Hosp Bull pmid:13068740
FOJUDZKI E et al. [Treatment of epidemic infantile paralysis in the acute stage]. 1951 Pol Tyg Lek (Wars) pmid:14929702
BETTLEY FR and FAIRBURN EA Treatment of some bullous eruptions with aureomycin and chloramphenicol. 1951 Br Med J pmid:14858848
CHANDLER CA et al. Studies on resistance of staphylococci to penicillin: the production of penicillinase and its inhibition by the action of aureomycin. 1951 Bull Johns Hopkins Hosp pmid:14859025
BELL MC et al. The effect of aureomycin on digestion in steers. 1951 Proc. Soc. Exp. Biol. Med. pmid:14827900
NAPP JH [Modern mastitis prevention]. 1951 Dtsch. Med. Wochenschr. pmid:14859846
WAISMAN HA et al. Role of aureomycin and citrovorum factor in "folic acid" deficiencies. 1951 Proc. Soc. Exp. Biol. Med. pmid:14827934
HERVET E and TORRE M [Aureomycin and abscesses of the breast]. 1951 Prog Med (Paris) pmid:14827952
BUSER F [Treatment of whooping cough with chloramphenicol and aureomycin]. 1951 Schweiz Med Wochenschr pmid:14834832
WRIGHT LT et al. Aureomycin as an adjunct in the treatment of major burns. 1951 Surgery pmid:14835170
WRIGHT LT et al. An evaluation of aureomycin therapy in peritonitis; a report of 235 consecutive cases. 1951 Surg Gynecol Obstet pmid:14835228
PATTON IJ Aureomycin: a review. 1951 Med Illus pmid:14826374
HAMILTON CI and PERKINS EK Anal herpes with generalized varicelliform eruption. Report of a case. 1951 Calif Med pmid:14792379
CAMERON HS The bactericidal action in vivo of aureomycin in an aureomycin fermentation residue against Brucella suis. 1951 Cornell Vet pmid:14840005
GOLDBLOOM RS and STEIGMANN F Aureomycin therapy in hepatic insufficiency. 1951 Gastroenterology pmid:14840589